FET PET Radiomics in Neuro-Oncology
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 16 August 2024 | Viewed by 1695
Special Issue Editors
Interests: glioma; image guided radiotherapy; brain metastases; meningioma; radiomics; FET-PET; UHF MRI
Interests: cancer imaging; image post-processing; computer-assisted radiographic image interpretation; computer-assisted diagnosis; 3D-imaging
Special Issue Information
Dear Colleagues,
Radiomics is a rapidly emerging field that involves the extraction and analysis of large amounts of quantitative imaging data from medical images. This approach allows for the identification of subtle patterns and features in the images that are not visible to the human eye. Radiomics has shown great potential for improving the accuracy of diagnosis and prognosis in a wide range of diseases, including brain tumors.
FET PET (18F-fluoro-ethyl-tyrosine positron emission tomography) has shown great promise in improving the accuracy of tumor detection, as well as guiding treatment decisions and monitoring treatment response. By combining the quantitative data extracted through radiomics with the specific information provided by FET PET imaging, researchers and clinicians can gain a more comprehensive understanding of brain tumors and their characteristics. This has the potential to lead to more accurate diagnosis and treatment decisions, as well as improved patient outcomes.
This Special Issue aims to give a comprehensive overview of the current standing of the field, to offer a platform to report the latest developments (clinical and translational), and to discuss future steps to move FET PET radiomics forward.
In this Special Issue, original research articles and reviews are welcome. We look forward to receiving your contributions.
Dr. Inge Compter
Dr. Alberto Traverso
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- FET-PET MRI
- glioma
- brain metastases
- tumor grade
- survival
- radiation necrosis
- pseudoprogression
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: DOTA PET
Author: Irina
Highlights: PET/CT；DOTA PET
